Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Cash from Discontinued Operations (2023 - 2024)

Updated

Addex Therapeutics (ADXN) reported Cash from Discontinued Operations of $6,697 for Q3 2024, compared with -$1.92 million a year earlier and down 99.8% from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Cash from Discontinued Operations (2023 - 2024) Analysis & Trends

Over the twelve months ended Sep 30, 2024, Addex Therapeutics' Cash from Discontinued Operations came in at -$219,886.

  • Five-year quarterly Cash from Discontinued Operations spans a low of -$2.24 million in Q1 2023 and a high of $3.7 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Addex Therapeutics 3.65 Mn -3.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -11.98 Mn
Jun 30, 2024 15.38 Mn
Mar 31, 2024 -2.20 Mn
Sep 30, 2023 -2.16 Mn
Jun 30, 2023 -2.40 Mn
Mar 31, 2023 -2.20 Mn
API Access

Addex Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ADXN&period=max&api_key=YOUR_API_KEY